Research & Development

light-accordion-a

single

Scientific expertise that powers credible R&D innovation.

h3

ZS’s scientists, physicians and computational biologists bring hands-on lab and data experience to every engagement. Our Ph.D.s and MDs power life sciences innovation by applying deep scientific understanding to build credible, reproducible and regulatory-grade clinical R&D solutions that advance the science of drug development.

false

Call to action

Deep domain and regulatory expertise across the R&D continuum.

h3

ZS’s experience spans the full life sciences research and development value chain, from early discovery to evidence generation. Our drug development consulting teams understand the business, data and regulatory realities of pharma R&D, helping clients reduce cycle times, raise success rates and get more therapies to patients faster.

false

Call to action

R&D data and analytics solutions that drive confident decisions.

h3

ZS helps organizations master complex R&D data ecosystems. By connecting research, clinical trial solutions and real-world evidence, we create analytics solutions that improve predictability, automate workflows and strengthen decision-making across the life sciences research and development continuum.

false

Call to action

Generative AI and emerging tech for transforming R&D.

h3

ZS is leading a wave of digital transformation in R&D through advanced AI and computational modeling. Recognized as a leader in IDC MarketScape’s Worldwide Life Sciences R&D AI (including GenAI) in Clinical Trials 2025 Vendor Assessment, we embed generative AI, digital twins and in silico techniques into discovery, clinical and evidence workflows to simulate experiments, predict outcomes and accelerate scientific decision-making. These innovations reduce cycle time, improve accuracy and unlock new frontiers of pharma R&D productivity.

false

Call to action

Scaled impact with flexible platforms and products.

h3

Siloed tools and rigid tech stacks are the enemy of scale. ZS platforms and solutions such as ZS Discovery, RBQM360 and ZAIDYN Clinical accelerate digital transformation in R&D through modular design and seamless integration with systems like Veeva, Oracle and SAP. The result: faster rollouts, greater agility and outsized impact.

false

Call to action

Delivering more therapies with cross-functional, cross-sector expertise.

h3

Navigating today’s complexifying R&D landscape demands drug development consulting expertise spanning strategy, tech and domain fluency. We combine applied scientists, clinical development experts, solution architects and seasoned trial experts who deeply understand patient experiences and pharma R&D.

false

Call to action

Collaborating to shape the future of R&D.

h3

ZS partners with clients, advisors and industry leaders to challenge the status quo, share insights and co-create innovative solutions that advance life sciences research and development.

false

Call to action

light-accordion-a

single

true

How can pharma R&D teams modernize their technology infrastructure and processes for better innovation?

h3

Life sciences research and development (R&D) organizations are under increasing pressure to evolve, but fragmented data, legacy systems and manual processes can slow innovation. ZS helps pharma R&D teams modernize their technology infrastructure and processes through modular, AI-powered solutions, cloud-native platforms, digital workflows and real-time data integration that support faster, more connected and innovation-driven decision-making.

false

Call to action

How does ZS enable digital transformation and digital enablement in life sciences R&D?

h3

ZS helps R&D teams streamline operations and eliminate silos with modular platforms, AI, automation, digital skills enablement and real-time data flow. From digital protocols to insight generation, we build scalable technology and adoption programs that help life sciences organizations improve system optimization, accelerate clinical trials and sustain long-term portfolio growth.

false

Call to action

What emerging technologies will generate the most value in pharma R&D and clinical development?

h3

Technologies such as generative AI, in silico trials, digital twins, quantum computing and AI-ready data platforms are redefining clinical R&D solutions. ZS enables digital transformation in R&D by helping organizations identify high-value use cases, optimize systems, improve trial design, reduce timelines and scale innovation across the life sciences value chain.

false

Call to action

How does ZS help pharma organizations align R&D strategy with measurable outcomes and scalable growth?

h3

ZS helps R&D leaders make smarter investment decisions, reduce risk and move with confidence. We work with organizations to define strategy up front, align teams early, build credible paths to scalable growth and focus execution on the outcomes that matter, so pipelines can deliver more impact, faster.

false

Call to action

Does ZS have expertise and domain fluency in pharma, oncology, rare disease and healthcare environments?

h3

Yes. ZS brings deep domain fluency across pharma, biotech, oncology, rare disease, medical affairs and broader healthcare environments. We support rare disease strategies including patient journey mapping, diagnosis acceleration, evidence generation and cross-functional collaboration, while also bringing advanced analytics and consulting capabilities to oncology across tumor types and launch planning.

ZS has supported 80% of drug launches in oncology in the last five years and more than 100 client engagements across more than 35 tumor types.

false

Call to action

How can I modernize my medical affairs function with technology adoption, insights and evidence generation?

h3

Legacy medical affairs programs are too often reactive and disconnected from the broader R&D organization. ZS supports medical affairs organizations from strategy to implementation with compliant and scalable AI-enabled insights, modular platforms, technology adoption research, cross-functional integration, digital skills enablement and better measurement of impact on patient outcomes.

false

Call to action

What is life sciences strategy consulting, and how does ZS support strategy implementation?

h3

Life sciences strategy consulting helps organizations define where to invest, how to operate and how to turn scientific, clinical and commercial priorities into measurable outcomes. ZS supports life sciences strategy implementation by connecting R&D strategy, advanced analytics, operating model design, technology platforms and change management so teams can move from planning to execution with greater speed and confidence.

false

Call to action

Where can pharma companies find integrated drug discovery and development support?

h3

ZS brings together research and discovery, clinical development, medical affairs and evidence capabilities to support organizations across the R&D continuum. Our teams combine scientific expertise, advanced analytics, bioinformatics, digital platforms and consulting services to help pharma and biotech companies connect early discovery through development and evidence generation.

false

Call to action